Literature DB >> 8425672

Immunochemical detection of advanced glycation end products in lens crystallins from streptozocin-induced diabetic rat.

H Nakayama1, T Mitsuhashi, S Kuwajima, S Aoki, Y Kuroda, T Itoh, S Nakagawa.   

Abstract

To reassess the significance of AGEs in cataract formation in diabetic animals, we measured amounts of AGEs in lens crystallins from STZ-induced diabetic animals with a newly developed ELISA. Lenses were removed at 5 and 20 wk after STZ injection. In 20-wk diabetic rats, all lenses were cataractous but not in control rats. In 20-wk diabetic compared with control rats, significant increases were observed in AGEs (172.3 +/- 18.3 vs. 14.3 +/- 1.7 AU, P < 0.01) and fluorescence (2.04 +/- 0.22 vs. 1.27 +/- 0.10 AU, P < 0.05). The amounts of AGEs in lens crystallins, measured by the ELISA, were > 12-fold higher in diabetic rats. In agreement with earlier studies, we found that fluorescence in lens crystallins increased by 61% in diabetic rats. In 5-wk diabetic rats, all lenses were noncataractous. In 5-wk diabetic compared with control rats, significant increases were observed in AGEs (84.1 +/- 7.7 vs. 9.4 +/- 1.5 AU, P < 0.01) and fluorescence (1.45 +/- 0.06 vs. 1.05 +/- 0.06 AU, P < 0.01). Analysis of the AGE content by ELISA showed that accumulation of AGEs in diabetic lens crystallins does markedly occur with time, and a large amount of AGEs exists in the diabetic (cataractous) lens crystallins. The disproportionate elevation of AGEs, measured by the ELISA, compared with fluorescence suggests that the actual levels of AGEs in cataractous lens crystallins from diabetic animals are higher than previously anticipated, and nonfluorescent AGEs may exist in diabetic lens crystallins.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425672     DOI: 10.2337/diab.42.2.345

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  28 in total

1.  Identification of glucose-derived cross-linking sites in ribonuclease A.

Authors:  Zhenyu Dai; Benlian Wang; Gang Sun; Xingjun Fan; Vernon E Anderson; Vincent M Monnier
Journal:  J Proteome Res       Date:  2008-05-24       Impact factor: 4.466

2.  Immunohistochemical localisation of advanced glycation end products in pulmonary fibrosis.

Authors:  T Matsuse; E Ohga; S Teramoto; M Fukayama; R Nagai; S Horiuchi; Y Ouchi
Journal:  J Clin Pathol       Date:  1998-07       Impact factor: 3.411

3.  Simultaneous noninvasive clinical measurement of lens autofluorescence and rayleigh scattering using a fluorescence biomicroscope.

Authors:  John Burd; Stephen Lum; Frederick Cahn; Keith Ignotz
Journal:  J Diabetes Sci Technol       Date:  2012-11-01

4.  Kaempferol modulates pro-inflammatory NF-kappaB activation by suppressing advanced glycation endproducts-induced NADPH oxidase.

Authors:  Ji Min Kim; Eun Kyeong Lee; Dae Hyun Kim; Byung Pal Yu; Hae Young Chung
Journal:  Age (Dordr)       Date:  2010-01-13

5.  Bendazac decreases in vitro glycation of human lens crystallins. Decrease of in vitro protein glycation by bendazac.

Authors:  C Marques; J S Ramalho; P Pereira; M C Mota
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

6.  Advanced glycation end products in human optic nerve head.

Authors:  S Amano; Y Kaji; T Oshika; T Oka; R Machinami; R Nagai; S Horiuchi
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

7.  Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody.

Authors:  S Kume; M Takeya; T Mori; N Araki; H Suzuki; S Horiuchi; T Kodama; Y Miyauchi; K Takahashi
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

8.  Age-dependent accumulation of advanced glycation endproducts is accelerated in combined hyperlipidemia and hyperglycemia, a process attenuated by L-arginine.

Authors:  A Georgescu; D Popov
Journal:  J Am Aging Assoc       Date:  2000-01

9.  Glycyrrhizin ameliorates metabolic syndrome-induced liver damage in experimental rat model.

Authors:  Rajarshi Sil; Doel Ray; Abhay Sankar Chakraborti
Journal:  Mol Cell Biochem       Date:  2015-09-23       Impact factor: 3.396

10.  Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis.

Authors:  Timothy J Lyons; Alicia J Jenkins
Journal:  Diabetes Rev (Alex)       Date:  1997
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.